\
&
Contact us
\
&
Contact us
In a collaborative effort involving hundreds of experts from across the European textile ecosystem, the SRIA identifies 3 main priority areas:
- Commission Press release of the launch of the Partnership
- Textile ETP news item on the launch of the Partnership
- In July 2024, Textile ETP published the Strategic Research and Innovation Agenda (SRIA) for the Partnership. Developed by Textile ETP with input from its members, the SRIA addresses the major challenges of the ongoing green and digital transition in the textile sector.
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
Ria.debreucker@vlaio.be
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
